Lochmüller Lab Welcomes New Students

Our lab is growing! We are excited to introduce two new students who have joined the Lochmüller Lab this fall.

 

Kelly Ho

Kelly has joined as a Master’s student in Cellular and Molecular Medicine to study the effects of forskolin and salbutamol in a mouse model for congenital myasthenic syndrome (CMS). She recently graduated with a BSc in Specialized Honours Kinesiology & Health Science at York University in 2021. During her undergraduate studies, she completed an Honours Thesis under the supervision of Dr. Dorota Anna Crawford, where she examined the motor coordination and dendritic morphology in the cerebellum of a mouse model for autism spectrum disorder (ASD).

 

Kelly looks forward to learning new techniques and gaining research experience as a part of the Lochmüller lab.

 

Ofosu Adjei-Afriyie

Ofosu Adjei-Afriyie is a 4th year undergraduate student in Translational and Molecular Medicine. Prior to entering the lab as an honours student, Ofosu conducted research under the supervison of Dr. Adam Rudner. With Dr. Rudner, he has discovered his own M. foliorum bacteriophage and has gone on to annotate and characterize an additional bacteriophage. In the winter of 2021, Ofosu extended his research with Dr. Rudner to investigate an uncharacterized tail assembly chaperone frameshift in bacteriophage Winzigispinne.

 

For his undergraduate honours project, Ofosu has joined the Lochmüller lab to study the therapeutic effects of MuSK agonist antibodies on mutant AGRIN CMS mice models.

https://lochmullerlab.org/files/cropped-LochmullerLab_web.jpg

Read next...

Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...